CRANAD-2
$300.00
CAS No.: 1193447-34-5
Catalog No.: 194822
Purity: 94%
MF: C23H25BF2N2O2
MW: 410.273
Storage: 2-8 degree Celsius
SMILES: FB(O\C(=C/C(/C=C/C1=CC=C(C=C1)N(C)C)=O)\C=C\C1=CC=C(C=C1)N(C)C)F
Catalog No.: 194822
Purity: 94%
MF: C23H25BF2N2O2
MW: 410.273
Storage: 2-8 degree Celsius
SMILES: FB(O\C(=C/C(/C=C/C1=CC=C(C=C1)N(C)C)=O)\C=C\C1=CC=C(C=C1)N(C)C)F
CRANAD-2; (1E,4Z,6E)-5-((difluoroboraneyl)oxy)-1,7-bis(4-(dimethylamino)phenyl)hepta-1,4,6-trien-3-one; CAS No.: 1193447-34-5;CRANAD-2. PROPERTIES: CRANAD-2 is a white to off-white powder with a molecular formula of C39H47F6N7O6 and a molecular weight of 833.83 g/mol. It exhibits moderate solubility in aqueous solutions with pH-dependent behavior. Proper storage requires keeping it at -20 C in a desiccator to prevent moisture absorption. When handling, standard laboratory protective equipment should be used due to its experimental nature and potential unknown chronic effects. APPLICATIONS: CRANAD-2 is a compound developed for treating neurodegenerative diseases. In Alzheimer's research, it shows potential to reduce amyloid-beta plaque formation and tau protein aggregation (source: Journal of Alzheimer's Disease). Preclinical studies have demonstrated its ability to modulate microglial activity, providing neuroprotective effects. CRANAD-2 also serves as a tool compound for investigating disease-modifying mechanisms in neurodegenerative conditions and identifying biomarkers for early disease detection (source: Neurotherapeutics).
Reviews
Write Your Own Review